Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px
Document › Details

Medigene AG. (5/24/18). "Press Release: Medigene Announces Capital Increase to Fund Immunotherapy Programs [NOT FOR UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAWS]". Pla

Organisations Organisation Medigene AG (FSE: MDG1, Prime Standard)
  Group Medigene (Group)
  Organisation 2 QVT Financial L.P.
  Group QVT (Group)
Products Product T cell therapy
  Product 2 investment banking
Index term Index term Medigene–SEVERAL: investment, 201805 private placement €32.3m 2.23m new shares at €14.5/share to institutional investors
Persons Person Manchester, Keith (QVT 201705 Managing Director + Head Life Sciences QVT Financial LP)
  Person 2 Schendel, Dolores J. (Medigene 201602– CEO before CMO before Trianta Immunotherapies + HelmholtzZentrum München)
     


   
Record changed: 2018-05-25

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Medigene (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x80px




» top